Jinqi Yu - Shanghai Pharmaceuticals G Mang

601607 Stock   19.23  0.02  0.10%   

Executive

Jinqi Yu is G Mang of Shanghai Pharmaceuticals Holding
Phone86 21 6373 0908
Webhttps://www.sphchina.com

Shanghai Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of 0.0241 % which means that it generated a profit of $0.0241 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0641 %, meaning that it generated $0.0641 on every $100 dollars invested by stockholders. Shanghai Pharmaceuticals' management efficiency ratios could be used to measure how well Shanghai Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

EXECUTIVE Age

Yun LongJahen Household Products
55
Wenduo WangAnshan Senyuan Road
59
Huanbin ZengJahen Household Products
51
Jie HaoAnshan Senyuan Road
N/A
Yu WangSilkroad Visual Technology
41
Haiyong ZhangAnshan Senyuan Road
55
Hemian JinAnshan Senyuan Road
N/A
Qiuyong LiaoMarssenger Kitchenware Co
40
Congyan XuJahen Household Products
50
Hong CaoSichuan Fulin Transportation
44
Er HuGuangzhou Seagull Kitchen
47
Yanyang ShiGuangzhou Seagull Kitchen
51
Nan ZhangAnshan Senyuan Road
N/A
Yanhong ZhaoAnshan Senyuan Road
56
Mingyuan LiSichuan Fulin Transportation
44
Xue HanZhengping RoadBridge Constr
N/A
Xun YuanGuangzhou Seagull Kitchen
59
Weiguo ZhaoSichuan Fulin Transportation
36
Weijiang QiAnshan Senyuan Road
N/A
Weiping MaoMarssenger Kitchenware Co
53
Shanghai Pharmaceuticals Holding (601607) is traded on Shanghai Stock Exchange in China and employs 48,164 people. Shanghai Pharmaceuticals is listed under Health Care Providers & Services category by Fama And French industry classification.

Management Performance

Shanghai Pharmaceuticals Leadership Team

Elected by the shareholders, the Shanghai Pharmaceuticals' board of directors comprises two types of representatives: Shanghai Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Shanghai. The board's role is to monitor Shanghai Pharmaceuticals' management team and ensure that shareholders' interests are well served. Shanghai Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Shanghai Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Shuai Shao, Vice President
Qiuhua Yang, Executive Chairman
Ying Ke, Director Center
Tao Zhong, Board VP
Man Cho, Pres Director
Shunjiang Yu, Chief Officer
Bo CPA, CFO and Presidentident
Ming Dong, Executive Director
Dongming Li, Vice President
Yongzhong Li, VP Director
Jinqi Yu, G Mang
Shui ACS, Joint Secretary
Pui Wong, Joint Secretary
Bo Shen, CFO, President
Linqiong Dong, Securities Representative

Shanghai Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Shanghai Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Shanghai Stock

Shanghai Pharmaceuticals financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Pharmaceuticals security.